Jinoos Yazdany, MD, MPH

Professor

Dr. Yazdany is Chief of the Division of Rheumatology at Zuckerberg San Francisco General Hospital (ZSFG) and the Alice Betts Endowed Professor of Medicine at UCSF. She received her undergraduate degree from Stanford, her MD from UCLA, and her MPH from Harvard. She joined the faculty after completing internal medicine residency and fellowship in rheumatology at UCSF. As a rheumatologist specializing in systemic lupus, she practices at ZSFG and co-directs the UCSF Health Lupus Clinic.

Dr. Yazdany’s scholarship focuses on improving health care quality, safety and outcomes for individuals with chronic rheumatic diseases. She co-directs the UCSF Rheumatology Quality and Informatics Lab, an interdisciplinary group that uses health services research, informatics, and implementation science to inform national health care improvement initiatives. She has worked with colleagues to develop the American College of Rheumatology’s RISE registry that aggregates and analyzes data from rheumatology practices around the country to inform quality improvement and research projects. She has developed a number of quality measures that have been endorsed by the National Quality Forum and are being used in federal programs. She has served as PI of grants from the NIH/NIAMS, AHRQ, and CDC and is the recipient of a NIAMS K24 mentoring award. Dr. Yazdany also serves as co-director of a research core – one focused on human subjects recruitment and clinical informatics support – for the NIH/NIAMS-funded P30 UCSF PREMIER Center.

Nationally, Dr. Yazdany has held numerous leadership positions, including serving as co-chair of the ACR’s Quality Measures Subcommittee, chair of the ACR’s Registries and Health IT Committee, chair of Research and Publications for the RISE registry, and member of the NQF’s Health Professional Council. She has earned several honors and awards for her work, including the Mary Betty Stevens Young Investigator Prize from the Lupus Foundation of America, the Ephraim Engleman Award for Arthritis Research, and the Hulda Irene Duggan Arthritis Investigator Award from the Arthritis Foundation.
Education
M.D., 2000 - School of Medicine, University of California Los Angeles
Residency, - Internal Medicine, University of California, San Francisco
Websites
Publications
  1. Bermas BL, Gianfrancesco M, Tanner HL, Seet AM, Aguiar MC, Al Adhoubi NK, Emadi SA, Cunha BM, Flood R, Kusevich DA, McCarthy EM, Patel NJ, Ruderman E, Sattui SE, Sciascia S, Siddique F, Valenzuela-Almada MO, Wise LM, Worthing AB, Zell J, Bhana S, Costello W, Duarte-Garcia A, Grainger R, Gossec L, Hausmann JS, Hyrich K, Lawson-Tovey S, Liew JW, Sirotich E, Sparks J, Sufka P, Wallace Z, Machado PM, Strangfeld A, Clowse MEB, Yazdany J, Robinson PC. COVID-19 in women with rheumatic disease who are pregnant: Data from the COVID-19 Global Rheumatology Alliance. 2021. PMID: 34470798


  2. Sattui SE, Liew JW, Kennedy K, Sirotich E, Putman M, Moni TT, Akpabio A, Alpízar-Rodríguez D, Berenbaum F, Bulina I, Conway R, Singh AD, Duff E, Durrant KL, Gheita TA, Hill CL, Howard RA, Hoyer BF, Hsieh E, El Kibbi L, Kilian A, Kim AH, Liew DFL, Lo C, Miller B, Mingolla S, Nudel M, Palmerlee CA, Singh JA, Singh N, Ugarte-Gil MF, Wallace J, Young KJ, Bhana S, Costello W, Grainger R, Machado PM, Robinson PC, Sufka P, Wallace ZS, Yazdany J, Harrison C, Larché M, Levine M, Foster G, Thabane L, Rider LG, Hausmann JS, Simard JF, Sparks JA. Early experience of COVID-19 vaccination in adults with systemic rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance Vaccine Survey. 2021. PMID: 34493645


  3. Anastasiou C, Trupin L, Glidden DV, Li J, Gianfrancesco M, Shiboski S, Schmajuk G, Yazdany J. Mortality among Hospitalized Individuals with Systemic Lupus Erythematosus in the United States between 2006 and 2016. 2020. PMID: 32558160


  4. Schmajuk G, Montgomery AD, Leonard S, Li J, Gianfrancesco M, Seet A, Izadi Z, Yazdany J, Keyhani S. Factors Associated With Hospitalization and Death After COVID-19 Diagnosis Among Patients With Rheumatic Disease: An Analysis of Veterans Affairs Data. 2021. PMID: 34423917


  5. Li J, Ringold S, Curtis JR, Michaud K, Johansson T, Yun H, Yazdany J, Schmajuk G. Effects of the SARS-CoV-2 global pandemic on U.S. rheumatology outpatient care delivery and use of telemedicine: an analysis of data from the RISE registry. 2021. PMID: 34338816


  6. Izadi Z, Li J, Evans M, Hammam N, Katz P, Ogdie A, Suter LG, Yazdany J, Schmajuk G. Socioeconomic Disparities in Functional Status in a National Sample of Patients With Rheumatoid Arthritis. 2021. PMID: 34347058


  7. Hausmann JS, Kennedy K, Simard JF, Liew JW, Sparks JA, Moni TT, Harrison C, Larché MJ, Levine M, Sattui SE, Semalulu T, Foster G, Surangiwala S, Thabane L, Beesley RP, Durrant KL, Mateus EF, Mingolla S, Nudel M, Palmerlee CA, Richards DP, Liew DFL, Hill CL, Bhana S, Costello W, Grainger R, Machado PM, Robinson PC, Sufka P, Wallace ZS, Yazdany J, Sirotich E, COVID-19 Global Rheumatology Alliance. Immediate effect of the COVID-19 pandemic on patient health, health-care use, and behaviours: results from an international survey of people with rheumatic diseases. 2021. PMID: 34316727


  8. Subash M, Liu LH, DeQuattro K, Choden S, Jacobsohn L, Katz P, Bajaj P, Barton JL, Bartels C, Bermas B, Danila MI, Downey C, Ferguson S, Reiter K, Wahl E, Weinstein E, Zell J, Schmajuk G, Yazdany J. The Development of the Rheumatology Informatics System for Effectiveness Learning Collaborative for Improving Patient-Reported Outcome Collection and Patient-Centered Communication in Adult Rheumatology. 2021. PMID: 34288595


  9. Kuriakose S, Singh K, Pau AK, Daar E, Gandhi R, Tebas P, Evans L, Gulick RM, Lane HC, Masur H, NIH COVID-19 Treatment Guidelines Panel , Aberg JA, Adimora AA, Baker J, Kreuziger LB, Bedimo R, Belperio PS, Cantrill SV, Coopersmith CM, Davis SL, Dzierba AL, Gallagher JJ, Glidden DV, Grund B, Hardy EJ, Hinkson C, Hughes BL, Johnson S, Keller MJ, Kim AY, Lennox JL, Levy MM, Li JZ, Martin GS, Naggie S, Pavia AT, Seam N, Simpson SQ, Swindells S, Tien P, Waghmare AA, Wilson KC, Yazdany J, Zachariah P, Campbell DM, Harrison C, Burgess T, Francis J, Sheikh V, Uyeki TM, Walker R, Brooks JT, Ortiz LB, Davey RT, Doepel LK, Eisinger RW, Han A, Higgs ES, Nason MC, Crew P, Lerner AM, Lund C, Worthington C. Developing Treatment Guidelines During a Pandemic Health Crisis: Lessons Learned From COVID-19. 2021. PMID: 34125574


  10. Sparks JA, Wallace ZS, Seet AM, Gianfrancesco MA, Izadi Z, Hyrich KL, Strangfeld A, Gossec L, Carmona L, Mateus EF, Lawson-Tovey S, Trupin L, Rush S, Katz P, Schmajuk G, Jacobsohn L, Wise L, Gilbert EL, Duarte-García A, Valenzuela-Almada MO, Pons-Estel GJ, Isnardi CA, Berbotto GA, Hsu TY, D'Silva KM, Patel NJ, Kearsley-Fleet L, Schäfer M, Ribeiro SLE, Al Emadi S, Tidblad L, Scirè CA, Raffeiner B, Thomas T, Flipo RM, Avouac J, Seror R, Bernardes M, Cunha MM, Hasseli R, Schulze-Koops H, Müller-Ladner U, Specker C, Souza VA, Mota LMHD, Gomides APM, Dieudé P, Nikiphorou E, Kronzer VL, Singh N, Ugarte-Gil MF, Wallace B, Akpabio A, Thomas R, Bhana S, Costello W, Grainger R, Hausmann JS, Liew JW, Sirotich E, Sufka P, Robinson PC, Machado PM, Yazdany J, COVID-19 Global Rheumatology Alliance. Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis: Results from the COVID-19 Global Rheumatology Alliance physician registry. 2021. PMID: 34049860


  11. Hyrich KL, Schäfer M, Strangfeld A, Carmona L, Gossec L, Mateus EF, Lawson-Tovey S, Gianfrancesco M, Robinson PC, Yazdany J, Machado PM. Response to: 'Correspondence on 'Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician reported registry'' by Rosenbaum et al. 2021. PMID: 33985941


  12. Strait A, Graf J, Margaretten M, Yazdany J, Goglin S. Race, Ethnicity and Disparities in Rheumatology Educational Materials. 2021. PMID: 33768717


  13. Conway R, Konig MF, Graef ER, Webb K, Yazdany J, Kim AHJ. Inflammatory arthritis in patients with COVID-19. 2021. PMID: 33626415


  14. Gianfrancesco MA, Leykina LA, Izadi Z, Taylor T, Sparks JA, Harrison C, Trupin L, Rush S, Schmajuk G, Katz P, Jacobsohn L, Hsu TY, D'Silva KM, Serling-Boyd N, Wallwork R, Todd DJ, Bhana S, Costello W, Grainger R, Hausmann JS, Liew JW, Sirotich E, Sufka P, Wallace ZS, Machado PM, Robinson PC, Yazdany J. Race/ethnicity association with COVID-19 outcomes in rheumatic disease: Data from the COVID-19 Global Rheumatology Alliance Physician Registry. 2020. PMID: 33146001


  15. Calabrese LH, Winthrop K, Strand V, Yazdany J, Walter JE. Type I interferon, anti-interferon antibodies, and COVID-19. 2021. PMID: 33655222


  16. Strangfeld A, Schäfer M, Gianfrancesco MA, Lawson-Tovey S, Liew JW, Ljung L, Mateus EF, Richez C, Santos MJ, Schmajuk G, Scirè CA, Sirotich E, Sparks JA, Sufka P, Thomas T, Trupin L, Wallace ZS, Al-Adely S, Bachiller-Corral J, Bhana S, Cacoub P, Carmona L, Costello R, Costello W, Gossec L, Grainger R, Hachulla E, Hasseli R, Hausmann JS, Hyrich KL, Izadi Z, Jacobsohn L, Katz P, Kearsley-Fleet L, Robinson PC, Yazdany J, Machado PM. Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry. 2021. PMID: 33504483


  17. Patterson SL, Trupin L, Yazdany J, Dall'Era M, Lanata C, Dequattro K, Hartogensis W, Katz P. Physical Inactivity Independently Predicts Incident Depression in a Multi-Racial/Ethnic Systemic Lupus Cohort. 2021. PMID: 33421358


  18. Liew JW, Bhana S, Costello W, Hausmann JS, Machado PM, Robinson PC, Sirotich E, Sufka P, Wallace ZS, Yazdany J, Grainger R. The COVID-19 Global Rheumatology Alliance: evaluating the rapid design and implementation of an international registry against best practice. 2020. PMID: 32789449


  19. Feldman CH, Speyer C, Ashby R, Bermas B, Bhattacharyya S, Chakravarty E, Everett B, Ferucci E, Hersh AO, Marty FM, Merola JF, Ramsey-Goldman R, Rovin BH, Son MB, Tarter L, Waikar S, Yazdany J, Weissman JS, Costenbader KH. Development of a Set of Lupus-Specific Ambulatory Care Sensitive, Potentially Preventable Adverse Conditions: A Delphi Consensus Study. 2019. PMID: 31628721


  20. Katz P, Dall'Era M, Trupin L, Rush S, Murphy LB, Lanata C, Criswell LA, Yazdany J. The impact of limited health literacy on patient-reported outcomes in systemic lupus erythematosus. 2020. PMID: 32741118


  21. DeQuattro K, Trupin L, Murphy LB, Rush S, Criswell LA, Lanata CM, Dall'Era M, Katz P, Yazdany J. High Disease Severity Among Asians in a US Multiethnic Cohort of Individuals with Systemic Lupus Erythematosus. 2020. PMID: 33337580


  22. Dietz B, Katz P, Dall'Era M, Murphy LB, Lanata C, Trupin L, Criswell LA, Yazdany J. Major Depression and Adverse Patient-Reported Outcomes in Systemic Lupus Erythematosus: Results from the California Lupus Epidemiology Study. 2020. PMID: 32741124


  23. Hammam N, Evans M, Morgan E, Reimold A, Anastasiou C, Kay JL, Yazdany J, Schmajuk G. Treatment of Sarcoidosis in U.S. Rheumatology Practices: Data from ACR's Rheumatology Informatics System for Effectiveness (RISE) Registry. 2020. PMID: 33105057


  24. Pau AK, Aberg J, Baker J, Belperio PS, Coopersmith C, Crew P, Glidden DV, Grund B, Gulick RM, Harrison C, Kim A, Lane HC, Masur H, Sheikh V, Singh K, Yazdany J, Tebas P. Convalescent Plasma for the Treatment of COVID-19: Perspectives of the National Institutes of Health COVID-19 Treatment Guidelines Panel. 2020. PMID: 32976026


  25. Yazdany J. COVID-19 in Rheumatic Diseases: A Research Agenda. 2020. PMID: 32705748


  26. Schmajuk G, Li J, Evans M, Anastasiou C, Kay JL, Yazdany J. Quality of care for patients with SLE: data from the American College of Rheumatology's RISE registry. 2020. PMID: 32937019


  27. Izadi Z, Schmajuk G, Gianfrancesco M, Subash M, Evans M, Trupin L, Yazdany J. Rheumatology Informatics System for Effectiveness (RISE) Practices See Significant Gains in Rheumatoid Arthritis Quality Measures. 2020. PMID: 32937026


  28. Yazdany J, Pooley N, Langham J, Nicholson L, Langham S, Embleton N, Wang X, Desta B, Barut V, Hammond E. Systemic lupus erythematosus; stroke and myocardial infarction risk: a systematic review and meta-analysis. 2020. PMID: 32900883


  29. Hausmann JS, Sufka P, Bhana S, Liew JW, Machado PM, Wallace ZS, Costello W, Robinson PC, Yazdany J, Grainger R, Sirotich E. Conducting research in a pandemic: The power of social media. 2020. PMID: 32716838


  30. Gianfrancesco MA, McCulloch CE, Trupin L, Graf J, Schmajuk G, Yazdany J. Reweighting to address nonparticipation and missing data bias in a longitudinal electronic health record study. 2020. PMID: 32807591


  31. Gianfrancesco M, Hyrich KL, Yazdany J, Machado PM, Robinson PC. Response to: 'Glucocorticoid-induced relapse of COVID-19 in a patient with sarcoidosis' by Györfi et al. 2020. PMID: 32606045


  32. Wallace ZS, Bhana S, Hausmann JS, Robinson PC, Sufka P, Sirotich E, Yazdany J, Grainger R. The Rheumatology Community responds to the COVID-19 pandemic: the establishment of the COVID-19 global rheumatology alliance. 2020. PMID: 32374851


  33. Gianfrancesco M, Hyrich KL, Al-Adely S, Carmona L, Danila MI, Gossec L, Izadi Z, Jacobsohn L, Katz P, Lawson-Tovey S, Mateus EF, Rush S, Schmajuk G, Simard J, Strangfeld A, Trupin L, Wysham KD, Bhana S, Costello W, Grainger R, Hausmann JS, Liew JW, Sirotich E, Sufka P, Wallace ZS, Yazdany J, Machado PM, Robinson PC. Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry. 2020. PMID: 32471903


  34. Clarke AE, Yazdany J, Kabadi SM, Durden E, Winer I, Griffing K, Costenbader KH. The economic burden of systemic lupus erythematosus in commercially- and medicaid-insured populations in the United States. 2020. PMID: 32531505


  35. Kulhawy-Wibe SC, Zell J, Michaud K, Yazdany J, Davis AM, Ehrlich-Jones L, Thorne JC, Everix D, Cappelli LC, Suter LG, Limanni A, Barber CEH. A Systematic Review and Appraisal of the Cross-Cultural Validity of Functional Status Assessments Measures in Rheumatoid Arthritis. 2019. PMID: 30980507


  36. Aggarwal I, Li J, Trupin L, Gaynon L, Katz PP, Lanata C, Criswell L, Murphy LB, Dall'Era M, Yazdany J. Quality of Care for the Screening, Diagnosis, and Management of Lupus Nephritis Across Multiple Healthcare Settings. 2019. PMID: 31058460


  37. Konig MF, Kim AH, Scheetz MH, Graef ER, Liew JW, Simard J, Machado PM, Gianfrancesco M, Yazdany J, Langguth D, Robinson PC. Baseline use of hydroxychloroquine in systemic lupus erythematosus does not preclude SARS-CoV-2 infection and severe COVID-19. 2020. PMID: 32381561


  38. Gianfrancesco MA, Hyrich KL, Gossec L, Strangfeld A, Carmona L, Mateus EF, Sufka P, Grainger R, Wallace Z, Bhana S, Sirotich E, Liew J, Hausmann JS, Costello W, Robinson P, Machado PM, Yazdany J. Rheumatic disease and COVID-19: initial data from the COVID-19 Global Rheumatology Alliance provider registries. 2020. PMID: 32309814


  39. Norgeot B, Muenzen K, Peterson TA, Fan X, Glicksberg BS, Schenk G, Rutenberg E, Oskotsky B, Sirota M, Yazdany J, Schmajuk G, Ludwig D, Goldstein T, Butte AJ. Protected Health Information filter (Philter): accurately and securely de-identifying free-text clinical notes. 2020. PMID: 32337372


  40. Liu LH, Garrett SB, Li J, Ragouzeos D, Berrean B, Dohan D, Katz PP, Barton JL, Yazdany J, Schmajuk G. Patient and clinician perspectives on a patient-facing dashboard that visualizes patient reported outcomes in rheumatoid arthritis. 2020. PMID: 32270591


  41. DeQuattro K, Trupin L, Li J, Katz PP, Murphy LB, Yelin EH, Rush S, Lanata C, Criswell LA, Dall'Era M, Yazdany J. Relationships Between Adverse Childhood Experiences and Health Status in Systemic Lupus Erythematosus. 2019. PMID: 31069933


  42. Schmajuk G, Li J, Evans M, Anastasiou C, Izadi Z, Kay JL, Hammam N, Yazdany J. RISE registry reveals potential gaps in medication safety for new users of biologics and targeted synthetic DMARDs. 2020. PMID: 32234243


  43. Lanata CM, Paranjpe I, Nititham J, Taylor KE, Gianfrancesco M, Paranjpe M, Andrews S, Chung SA, Rhead B, Barcellos LF, Trupin L, Katz P, Dall'Era M, Yazdany J, Sirota M, Criswell LA. Author Correction: A phenotypic and genomics approach in a multi-ethnic cohort to subtype systemic lupus erythematosus. 2020. PMID: 32109229


  44. Sammaritano LR, Bermas BL, Chakravarty EE, Chambers C, Clowse MEB, Lockshin MD, Marder W, Guyatt G, Branch DW, Buyon J, Christopher-Stine L, Crow-Hercher R, Cush J, Druzin M, Kavanaugh A, Laskin CA, Plante L, Salmon J, Simard J, Somers EC, Steen V, Tedeschi SK, Vinet E, White CW, Yazdany J, Barbhaiya M, Bettendorf B, Eudy A, Jayatilleke A, Shah AA, Sullivan N, Tarter LL, Birru Talabi M, Turgunbaev M, Turner A, D'Anci KE. 2020 American College of Rheumatology Guideline for the Management of Reproductive Health in Rheumatic and Musculoskeletal Diseases. 2020. PMID: 32090466


  45. Sammaritano LR, Bermas BL, Chakravarty EE, Chambers C, Clowse MEB, Lockshin MD, Marder W, Guyatt G, Branch DW, Buyon J, Christopher-Stine L, Crow-Hercher R, Cush J, Druzin M, Kavanaugh A, Laskin CA, Plante L, Salmon J, Simard J, Somers EC, Steen V, Tedeschi SK, Vinet E, White CW, Yazdany J, Barbhaiya M, Bettendorf B, Eudy A, Jayatilleke A, Shah AA, Sullivan N, Tarter LL, Birru Talabi M, Turgunbaev M, Turner A, D'Anci KE. 2020 American College of Rheumatology Guideline for the Management of Reproductive Health in Rheumatic and Musculoskeletal Diseases. 2020. PMID: 32090480


  46. Aguirre A, Trupin L, Margaretten M, Goglin S, Noh JH, Yazdany J. Using process improvement and systems redesign to improve rheumatology care quality in a safety net clinic. 2020. PMID: 32062597


  47. Barber CEH, Zell J, Yazdany J, Davis AM, Cappelli L, Ehrlich-Jones L, Everix D, Thorne JC, Bohm V, Suter L, Limanni A, Michaud K. 2019 American College of Rheumatology Recommended Patient-Reported Functional Status Assessment Measures in Rheumatoid Arthritis. 2019. PMID: 31709771


  48. Strait A, Castillo F, Choden S, Li J, Whitaker E, Falasinnu T, Schmajuk G, Yazdany J. Demographic Characteristics of Participants in Rheumatoid Arthritis Randomized Clinical Trials: A Systematic Review. 2019. PMID: 31722023


  49. Lanata CM, Paranjpe I, Nititham J, Taylor KE, Gianfrancesco M, Paranjpe M, Andrews S, Chung SA, Rhead B, Barcellos LF, Trupin L, Katz P, Dall'Era M, Yazdany J, Sirota M, Criswell LA. A phenotypic and genomics approach in a multi-ethnic cohort to subtype systemic lupus erythematosus. 2019. PMID: 31467281


  50. Izadi Z, Katz PP, Schmajuk G, Gandrup J, Li J, Gianfrancesco M, Yazdany J. Effects of language, insurance and race/ethnicity on measurement properties of the PROMIS Physical Function Short Form 10a in rheumatoid arthritis. 2018. PMID: 30099861


  51. Heshin-Bekenstein M, Trupin L, Yelin E, von Scheven E, Yazdany J, Lawson EF. Longitudinal disease- and steroid-related damage among adults with childhood-onset systemic lupus erythematosus. 2019. PMID: 31235075


  52. Singh JA, Fraenkel L, Green C, Alarcón GS, Barton JL, Saag KG, Hanrahan LM, Raymond SC, Kimberly RP, Leong AL, Reyes E, Street RL, Suarez-Almazor ME, Eakin GS, Marrow L, Morgan CJ, Caro B, Sloan JA, Jandali B, Garcia SR, Grossman J, Winthrop KL, Trupin L, Dall'Era M, Meara A, Rizvi T, Chatham WW, Yazdany J. Individualized decision aid for diverse women with lupus nephritis (IDEA-WON): A randomized controlled trial. 2019. PMID: 31067237


  53. Ying D, Gianfrancesco MA, Trupin L, Yazdany J, Greidinger E, Schmajuk G. Increased risk of ischemic stroke in systemic sclerosis: a national cohort study of US veterans. 2019. PMID: 30877213


  54. Norgeot B, Glicksberg BS, Trupin L, Lituiev D, Gianfrancesco M, Oskotsky B, Schmajuk G, Yazdany J, Butte AJ. Assessment of a Deep Learning Model Based on Electronic Health Record Data to Forecast Clinical Outcomes in Patients With Rheumatoid Arthritis. 2019. PMID: 30874779


  55. Patterson S, Schmajuk G, Evans M, Aggarwal I, Izadi Z, Gianfrancesco M, Yazdany J. Gaps in Ambulatory Patient Safety for Immunosuppressive Specialty Medications. 2019. PMID: 30686706


  56. Patterson SL, Schmajuk G, Jafri K, Yazdany J, Katz P. Obesity Independently Associates with Worse Patient-Reported Outcomes in Women with Systemic Lupus Erythematosus. 2018. PMID: 29740985


  57. Sciascia S, Yazdany J, Dall'Era M, Fenoglio R, Radin M, Aggarwal I, Cuadrado MJ, Schreiber K, Barreca A, Papotti M, Roccatello D. Anticoagulation in patients with concomitant lupus nephritis and thrombotic microangiopathy: a multicentre cohort study. 2018. PMID: 30552172


  58. Gianfrancesco MA, Trupin L, Shiboski S, van der Laan M, Graf J, Imboden J, Yazdany J, Schmajuk G. Smoking Is Associated with Higher Disease Activity in Rheumatoid Arthritis: A Longitudinal Study Controlling for Time-varying Covariates. 2018. PMID: 30504507


  59. Yazdany J, Caplan L, Fitzgerald J, Schmajuk G. Editorial: The Evolving Art and Science of American College of Rheumatology Guidelines. 2018. PMID: 30499229


  60. Arora S, Nika A, Trupin L, Abraham H, Block J, Sequeira W, Yazdany J, Jolly M. Does SLE Care provided in a Lupus Clinic Result in Higher Quality of Care Than General Rheumatology Clinic? 2018. PMID: 29609210


  61. Schmajuk G, Jafri K, Evans M, Shiboski S, Gianfrancesco M, Izadi Z, Patterson SL, Aggarwal I, Sarkar U, Dudley RA, Yazdany J. Pneumocystis jirovecii pneumonia (PJP) prophylaxis patterns among patients with rheumatic diseases receiving high-risk immunosuppressant drugs. 2018. PMID: 30449650


  62. Khoong EC, Cherian R, Rivadeneira NA, Gourley G, Yazdany J, Amarnath A, Schillinger D, Sarkar U. Accurate Measurement In California's Safety-Net Health Systems Has Gaps And Barriers. 2018. PMID: 30395496


  63. Schmajuk G, Yazdany J. Further Lessons in Pneumocystis Pneumonia Prophylaxis. 2018. PMID: 30398556


  64. Gianfrancesco MA, Tamang S, Yazdany J, Schmajuk G. Potential Biases in Machine Learning Algorithms Using Electronic Health Record Data. 2018. PMID: 30128552


  65. Ragouzeos D, Gandrup J, Berrean B, Li J, Murphy M, Trupin L, Yazdany J, Schmajuk G. "Am I OK?" using human centered design to empower rheumatoid arthritis patients through patient reported outcomes. 2018. PMID: 30446358


  66. Yazdany J, Dudley RA, Lin GA, Chen R, Tseng CW. Out-of-Pocket Costs for Infliximab and Its Biosimilar for Rheumatoid Arthritis Under Medicare Part D. 2018. PMID: 30193264


  67. Izadi Z, Gandrup J, Katz PP, Yazdany J. Patient-reported outcome measures for use in clinical trials of SLE: a review. 2018. PMID: 30167315


  68. Li J, Yazdany J, Trupin L, Izadi Z, Gianfrancesco M, Goglin S, Schmajuk G. Capturing a Patient-Reported Measure of Physical Function Through an Online Electronic Health Record Patient Portal in an Ambulatory Clinic: Implementation Study. Volume 6 of Issue 2. 2018. PMID: 29743158


  69. Yelin E, Yazdany J, Trupin L. The Relationship between Poverty and Mortality in Systemic Lupus Erythematosus. 2017. PMID: 28973834


  70. Heshin-Bekenstein M, Perl L, Hersh AO, von Scheven E, Yelin E, Trupin L, Yazdany J, Lawson EF. Final adult height of patients with childhood-onset systemic lupus erythematosus: a cross sectional analysis. Volume 16 of Issue 1. 2018. PMID: 29688869


  71. Ackerman SL, Gourley G, Le G, Williams P, Yazdany J, Sarkar U. Improving Patient Safety in Public Hospitals: Developing Standard Measures to Track Medical Errors and Process Breakdowns. 2018. PMID: 29543667


  72. Feldman CH, Broder A, Guan H, Yazdany J, Costenbader KH. Sex Differences in Health Care Utilization, End-Stage Renal Disease, and Mortality Among Medicaid Beneficiaries With Incident Lupus Nephritis. Volume 70 of Issue 3. 2018. PMID: 29193893


  73. Gianfrancesco MA, Schmajuk G, Haserodt S, Trupin L, Izadi Z, Jafri K, Shiboski S, Sirota M, Dudley RA, Yazdany J. Correction to: Hydroxychloroquine dosing in immune-mediated diseases: implications for patient safety. Volume 38 of Issue 2. 2018. PMID: 29273937


  74. Jafri K, Ogdie A, Qasim A, Patterson SL, Gianfrancesco M, Izadi Z, Katz P, Yazdany J, Schmajuk G. Discordance of the Framingham cardiovascular risk score and the 2013 American College of Cardiology/American Heart Association risk score in systemic lupus erythematosus and rheumatoid arthritis. Volume 37 of Issue 2. 2017. PMID: 28993952


  75. Schmajuk G, Yazdany J. Leveraging the electronic health record to improve quality and safety in rheumatology. Volume 37 of Issue 10. 2017. PMID: 28852846


  76. Gianfrancesco MA, Schmajuk G, Haserodt S, Trupin L, Izadi Z, Jafri K, Shiboski S, Sirota M. Hydroxychloroquine dosing in immune-mediated diseases: implications for patient safety. Volume 37 of Issue 10. 2017. PMID: 28748425


  77. Yelin E, Yazdany J, Trupin L. Relationship Between Process of Care and a Subsequent Increase in Damage in Systemic Lupus Erythematosus. Volume 69 of Issue 6. 2017. PMID: 27477567


  78. Schmajuk G, Tonner C, Trupin L, Yazdany J. Variations in Radiographic Procedure Use for Medicare Patients With Rheumatoid Arthritis. Volume 69 of Issue 5. 2017. PMID: 27390167


  79. Tseng CW, Yazdany J, Dudley RA, DeJong C, Kazi DS, Chen R, Lin GA. Medicare Part D Plans' Coverage and Cost-Sharing for Acute Rescue and Preventive Inhalers for Chronic Obstructive Pulmonary Disease. Volume 177 of Issue 4. 2017. PMID: 28241217


  80. Sciascia S, Radin M, Yazdany J, Tektonidou M, Cecchi I, Roccatello D, Dall'Era M. Expanding the therapeutic options for renal involvement in lupus: eculizumab, available evidence. Volume 37 of Issue 8. 2017. PMID: 28258475


  81. Katz P, Margaretten M, Schmajuk G, Yazdany J, Yelin E. Reply. Volume 69 of Issue 3. 2017. PMID: 28129462


  82. Schmajuk G, Tonner C, Trupin L, Li J, Sarkar U, Ludwig D, Shiboski S, Sirota M, Dudley RA, Murray S, Yazdany J. Using health-system-wide data to understand hepatitis B virus prophylaxis and reactivation outcomes in patients receiving rituximab. Volume 96 of Issue 13. 2017. PMID: 28353614


  83. Wahl E, Gross A, Chernitskiy V, Trupin L, Gensler L, Chaganti K, Michaud K, Katz P, Yazdany J. Validity and Responsiveness of a 10-Item Patient-Reported Measure of Physical Function in a Rheumatoid Arthritis Clinic Population. Volume 69 of Issue 3. 2017. PMID: 27332620


  84. Katz PP, Andrews J, Yazdany J, Schmajuk G, Trupin L, Yelin E. Is frailty a relevant concept in SLE? Volume 4 of Issue 1. 2017. PMID: 28243456


  85. Sciascia S, Radin M, Yazdany J, Levy RA, Roccatello D, Dall'Era M, Cuadrado MJ. Efficacy of belimumab on renal outcomes in patients with systemic lupus erythematosus: A systematic review. Volume 16 of Issue 3. 2017. PMID: 28147262


  86. Schmajuk G, Tonner C, Miao Y, Yazdany J, Gannon J, Boscardin WJ, Daikh DI, Steinman MA. Folic Acid Supplementation Is Suboptimal in a National Cohort of Older Veterans Receiving Low Dose Oral Methotrexate. 2016. PMID: 27977768


  87. Qu H, Shewchuk RM, Alarcón G, Fraenkel L, Leong A, Dall'Era M, Yazdany J, Singh JA. Mapping Perceptions of Lupus Medication Decision-Making Facilitators: The Importance of Patient Context. Volume 68 of Issue 12. 2016. PMID: 27059939


  88. Yazdany J, Bansback N, Clowse M, Collier D, Law K, Liao KP, Michaud K, Morgan EM, Oates JC, Orozco C, Reimold A, Simard JF, Myslinski R, Kazi S. Rheumatology Informatics System for Effectiveness: A National Informatics-Enabled Registry for Quality Improvement. Volume 68 of Issue 12. 2016. PMID: 27696755


  89. Yazdany J, Robbins M, Schmajuk G, Desai S, Lacaille D, Neogi T, Singh JA, Genovese M, Myslinski R, Fisk N, Francisco M, Newman E. Development of the American College of Rheumatology's Rheumatoid Arthritis Electronic Clinical Quality Measures. Volume 68 of Issue 11. 2016. PMID: 27564778


  90. Tseng CW, Lin GA, Davis J, Taira DA, Yazdany J, He Q, Chen R, Imamura A, Dudley RA. Giving formulary and drug cost information to providers and impact on medication cost and use: a longitudinal non-randomized study. Volume 16 of Issue 1. 2016. PMID: 27654857


  91. Suter LG, Barber CE, Herrin J, Leong A, Losina E, Miller A, Newman E, Robbins M, Tory H, Yazdany J. American College of Rheumatology White Paper on Performance Outcome Measures in Rheumatology. Volume 68 of Issue 10. 2016. PMID: 27159835


  92. Yazdany J, Myslinski R, Miller A, Francisco M, Desai S, Schmajuk G, Lacaille D, Barber CE, Orozco C, Bunyard M, Bergman MJ, Passo M, Matteson EL, Olson R, Silverman S, Warren R, Nola K, Robbins M. Methods for Developing the American College of Rheumatology's Electronic Clinical Quality Measures. Volume 68 of Issue 10. 2016. PMID: 27390129


  93. Bays A, Wahl E, Daikh DI, Yazdany J, Schmajuk G. Implementation of disease activity measurement for rheumatoid arthritis patients in an academic rheumatology clinic. Volume 16 of Issue a. 2016. PMID: 27527720


  94. Katz PP, Barton J, Trupin L, Schmajuk G, Yazdany J, Ruiz PJ, Yelin E. Poverty, Depression, or Lost in Translation? Ethnic and Language Variation in Patient-Reported Outcomes in Rheumatoid Arthritis. Volume 68 of Issue 5. 2016. PMID: 26414775


  95. Murray SG, Schmajuk G, Trupin L, Gensler L, Katz PP, Yelin EH, Gansky SA, Yazdany J. National Lupus Hospitalization Trends Reveal Rising Rates of Herpes Zoster and Declines in Pneumocystis Pneumonia. Volume 11 of Issue 1. 2016. PMID: 26731012


  96. Katz P, Margaretten M, Trupin L, Schmajuk G, Yazdany J, Yelin E. Role of Sleep Disturbance, Depression, Obesity, and Physical Inactivity in Fatigue in Rheumatoid Arthritis. Volume 68 of Issue 1. 2016. PMID: 25779719


  97. Singh JA, Qu H, Yazdany J, Chatham W, Shewchuk R. Minorities with lupus nephritis and medications: a study of facilitators to medication decision-making. Volume 17. 2015. PMID: 26680561


  98. Feldman CH, Yazdany J, Guan H, Solomon DH, Costenbader KH. Medication Nonadherence Is Associated With Increased Subsequent Acute Care Utilization Among Medicaid Beneficiaries With Systemic Lupus Erythematosus. Volume 67 of Issue 12. 2015. PMID: 26097166


  99. Davis LA, Goldstein B, Tran V, Keniston A, Yazdany J, Hirsh J, Storfa A, Zell J. Applying Choosing Wisely: Antinuclear Antibody (ANA) and Sub-Serology Testing in a Safety Net Hospital System. Volume 9. 2015. PMID: 26862352


  100. Sapir T, Rusie E, Greene L, Yazdany J, Robbins ML, Ruderman EM, Carter JD, Patel B, Moreo K. Influence of Continuing Medical Education on Rheumatologists' Performance on National Quality Measures for Rheumatoid Arthritis. Volume 2 of Issue 2. 2015. PMID: 27747535


  101. Scheibe MM, Imboden JB, Schmajuk G, Margaretten M, Graf JD, Chen AH, Yelin EH, Yazdany J. Efficiency Gains for Rheumatology Consultation Using a Novel Electronic Referral System in a Safety-Net Health Setting. Volume 67 of Issue 8. 2015. PMID: 25623810


  102. Andrews JS, Trupin L, Schmajuk G, Barton J, Margaretten M, Yazdany J, Yelin EH, Katz PP. Muscle Strength and Changes in Physical Function in Women With Systemic Lupus Erythematosus. Volume 67 of Issue 8. 2015. PMID: 25623919


  103. Schmajuk G, Tonner C, Yazdany J. Factors associated with access to rheumatologists for Medicare patients. Volume 45 of Issue 4. 2015. PMID: 26319646


  104. Singh JA, Qu H, Yazdany J, Chatham W, Dall'era M, Shewchuk RM. Barriers to Medication Decision Making in Women with Lupus Nephritis: A Formative Study using Nominal Group Technique. Volume 42 of Issue 9. 2015. PMID: 26178276


  105. Rai SK, Yazdany J, Fortin PR, Aviña-Zubieta JA. Approaches for estimating minimal clinically important differences in systemic lupus erythematosus. Volume 17. 2015. PMID: 26036334


  106. Duseja R, Bardach NS, Lin GA, Yazdany J, Dean ML, Clay TH, Boscardin WJ, Dudley RA. Revisit rates and associated costs after an emergency department encounter: a multistate analysis. Volume 162 of Issue 11. 2015. PMID: 26030633


  107. Yazdany J, Dudley RA, Chen R, Lin GA, Tseng CW. Coverage for high-cost specialty drugs for rheumatoid arthritis in Medicare Part D. Volume 67 of Issue 6. 2015. PMID: 25900105


  108. Murray SG, Schmajuk G, Trupin L, Lawson E, Cascino M, Barton J, Margaretten M, Katz PP, Yelin EH, Yazdany J. A population-based study of infection-related hospital mortality in patients with dermatomyositis/polymyositis. Volume 67 of Issue 5. 2015. PMID: 25331828


  109. Yelin E, Yazdany J, Tonner C, Trupin L, Criswell LA, Katz P, Schmajuk G. Interactions between patients, providers, and health systems and technical quality of care. Volume 67 of Issue 3. 2015. PMID: 25132660


  110. Schmajuk G, Bozic KJ, Yazdany J. Using medicare data to understand health care value--reply. Volume 175 of Issue 3. 2015. PMID: 25730567


  111. Andrews JS, Trupin L, Schmajuk G, Barton J, Margaretten M, Yazdany J, Yelin EH, Katz PP. Muscle strength, muscle mass, and physical disability in women with systemic lupus erythematosus. Volume 67 of Issue 1. 2015. PMID: 25049114


  112. Yazdany J, Tonner C, Schmajuk G, Lin GA, Trivedi AN. Receipt of glucocorticoid monotherapy among Medicare beneficiaries with rheumatoid arthritis. Volume 66 of Issue 10. 2014. PMID: 25244314


  113. Yazdany J, Marafino BJ, Dean ML, Bardach NS, Duseja R, Ward MM, Dudley RA. Thirty-day hospital readmissions in systemic lupus erythematosus: predictors and hospital- and state-level variation. Volume 66 of Issue 10. 2014. PMID: 25110993


  114. Schmajuk G, Bozic KJ, Yazdany J. Using Medicare data to understand low-value health care: the case of intra-articular hyaluronic acid injections. Volume 174 of Issue 10. 2014. PMID: 25156406


  115. Quinzanos I, Davis L, Keniston A, Nash A, Yazdany J, Fransen R, Hirsh JM, Zell J. Application and feasibility of systemic lupus erythematosus reproductive health care quality indicators at a public urban rheumatology clinic. 2014. PMID: 25267076


  116. Schmajuk G, Miao Y, Yazdany J, Boscardin WJ, Daikh DI, Steinman MA. Identification of risk factors for elevated transaminases in methotrexate users through an electronic health record. Volume 66 of Issue 8. 2014. PMID: 24470205


  117. Katz P, Trupin L, Rush S, Yazdany J. Longitudinal validation of the Brief Index of Lupus Damage. Volume 66 of Issue 7. 2014. PMID: 24376263


  118. Simard JF, Yazdany J. Challenges in understanding the role of pregnancy morbidity in cardiovascular risk in SLE. Volume 1 of Issue 1. 2014. PMID: 25379195


  119. Askanase AD, Yazdany J, Molta CT. Post-marketing experiences with belimumab in the treatment of SLE patients. Volume 40 of Issue 3. 2014. PMID: 25034159


  120. Drenkard C, Yazdany J, Trupin L, Katz PP, Dunlop-Thomas C, Bao G, Lim SS. Validity of a self-administered version of the brief index of lupus damage in a predominantly African American systemic lupus erythematosus cohort. Volume 66 of Issue 6. 2014. PMID: 24249662


  121. Lawson EF, Hersh AO, Trupin L, von Scheven E, Okumura MJ, Yazdany J, Yelin EH. Educational and vocational outcomes of adults with childhood- and adult-onset systemic lupus erythematosus: nine years of followup. Volume 66 of Issue 5. 2014. PMID: 24877200


  122. Yazdany J, Feldman CH, Liu J, Ward MM, Fischer MA, Costenbader KH. Quality of care for incident lupus nephritis among Medicaid beneficiaries in the United States. Volume 66 of Issue 4. 2014. PMID: 24124011


  123. Yazdany J, Trupin L, Schmajuk G, Katz PP, Yelin EH. Quality of care in systemic lupus erythematosus: the association between process and outcome measures in the Lupus Outcomes Study. Volume 23 of Issue 8. 2014. PMID: 24614054


  124. Lawson EF, Trupin L, Hersh AO, Scheven Ev, Yelin EH, Yazdany J. A168: systemic lupus erythematosus in-hospital mortality risk across ages: a national estimate. 2014. PMID: 24677924


  125. Desai SP, Liu CC, Tory H, Norton T, Frits M, Lillegraven S, Weinblatt M, Coblyn J, Yazdany J, Shadick N, Solomon DH. Rheumatoid arthritis quality measures and radiographic progression. Volume 44 of Issue 1. 2014. PMID: 24560878


  126. Schmajuk G, Solomon DH, Yazdany J. Patterns of disease-modifying antirheumatic drug use in rheumatoid arthritis patients after 2002: a systematic review. Volume 65 of Issue 12. 2013. PMID: 23926092


  127. Bardach NS, Vittinghoff E, Asteria-Peñaloza R, Edwards JD, Yazdany J, Lee HC, Boscardin WJ, Cabana MD, Dudley RA. Measuring hospital quality using pediatric readmission and revisit rates. Volume 132 of Issue 3. 2013. PMID: 23979094


  128. Grossman JM, Hahn BH, McMahon MA, Fitzgerald JD, Merrill JT, Yazdany J, Wallace DJ, Ramsey-Goldman R. Reply: To PMID 22556106. Volume 65 of Issue 8. 2013. PMID: 23495047


  129. Tarter L, Yazdany J, Moyers B, Barnett C, Dhaliwal G. Clinical problem-solving. The heart of the matter. Volume 368 of Issue 10. 2013. PMID: 23465105


  130. Yazdany J, Schmajuk G, Robbins M, Daikh D, Beall A, Yelin E, Barton J, Carlson A, Margaretten M, Zell J, Gensler LS, Kelly V, Saag K, King C. Choosing wisely: the American College of Rheumatology's Top 5 list of things physicians and patients should question. Volume 65 of Issue 3. 2013. PMID: 23436818


  131. Richman NC, Yazdany J, Graf J, Chernitskiy V, Imboden JB. Extraarticular manifestations of rheumatoid arthritis in a multiethnic cohort of predominantly Hispanic and Asian patients. Volume 92 of Issue 2. 2013. PMID: 23429352


  132. Katz PP, Yazdany J, Trupin L, Schmajuk G, Margaretten M, Barton J, Criswell LA, Yelin EH. Sex differences in assessment of obesity in rheumatoid arthritis. Volume 65 of Issue 1. 2013. PMID: 22833513


  133. Turchetti G, Yazdany J, Palla I, Yelin E, Mosca M. Systemic lupus erythematosus and the economic perspective: a systematic literature review and points to consider. Volume 30 of Issue 4 Suppl 73. 2012. PMID: 23072767


  134. Murray SG, Yazdany J, Kaiser R, Criswell LA, Trupin L, Yelin EH, Katz PP, Julian LJ. Cardiovascular disease and cognitive dysfunction in systemic lupus erythematosus. Volume 64 of Issue 9. 2012. PMID: 22549897


  135. Hahn BH, McMahon MA, Wilkinson A, Wallace WD, Daikh DI, Fitzgerald JD, Karpouzas GA, Merrill JT, Wallace DJ, Yazdany J, Ramsey-Goldman R, Singh K, Khalighi M, Choi SI, Gogia M, Kafaja S, Kamgar M, Lau C, Martin WJ, Parikh S, Peng J, Rastogi A, Chen W, Grossman JM. American College of Rheumatology guidelines for screening, treatment, and management of lupus nephritis. Volume 64 of Issue 6. 2012. PMID: 22556106


  136. Yazdany J, Trupin L, Tonner C, Dudley RA, Zell J, Panopalis P, Schmajuk G, Julian L, Katz P, Criswell LA, Yelin E. Quality of care in systemic lupus erythematosus: application of quality measures to understand gaps in care. Volume 27 of Issue 10. 2012. PMID: 22588825


  137. Anderson J, Caplan L, Yazdany J, Robbins ML, Neogi T, Michaud K, Saag KG, O'Dell JR, Kazi S. Rheumatoid arthritis disease activity measures: American College of Rheumatology recommendations for use in clinical practice. Volume 64 of Issue 5. 2012. PMID: 22473918


  138. Katz P, Julian L, Tonner MC, Yazdany J, Trupin L, Yelin E, Criswell LA. Physical activity, obesity, and cognitive impairment among women with systemic lupus erythematosus. Volume 64 of Issue 4. 2012. PMID: 22337564


  139. Julian LJ, Yazdany J, Trupin L, Criswell LA, Yelin E, Katz PP. Validity of brief screening tools for cognitive impairment in rheumatoid arthritis and systemic lupus erythematosus. Volume 64 of Issue 3. 2012. PMID: 22162414


  140. Yelin E, Tonner C, Trupin L, Gansky SA, Julian L, Katz P, Yazdany J, Kaiser R, Criswell LA. Longitudinal study of the impact of incident organ manifestations and increased disease activity on work loss among persons with systemic lupus erythematosus. Volume 64 of Issue 2. 2012. PMID: 22006458


  141. Desai SP, Yazdany J. Quality measurement and improvement in rheumatology: rheumatoid arthritis as a case study. Volume 63 of Issue 12. 2011. PMID: 22127687


  142. Barton JL, Pincus L, Yazdany J, Richman N, McCalmont TH, Gensler L, Dall'era M, Fye KH. Association of Sweet's Syndrome and Systemic Lupus Erythematosus. 2011. PMID: 22937442


  143. Katz P, Yazdany J, Julian L, Trupin L, Margaretten M, Yelin E, Criswell LA. Impact of obesity on functioning among women with systemic lupus erythematosus. Volume 63 of Issue 10. 2011. PMID: 21702085


  144. Yazdany J, Trupin L, Gansky SA, Dall'era M, Yelin EH, Criswell LA, Katz PP. Brief index of lupus damage: a patient-reported measure of damage in systemic lupus erythematosus. Volume 63 of Issue 8. 2011. PMID: 21584946


  145. Julian LJ, Gregorich SE, Tonner C, Yazdany J, Trupin L, Criswell LA, Yelin E, Katz PP. Using the Center for Epidemiologic Studies Depression Scale to screen for depression in systemic lupus erythematosus. Volume 63 of Issue 6. 2011. PMID: 21312347


  146. Julian LJ, Tonner C, Yelin E, Yazdany J, Trupin L, Criswell LA, Katz PP. Cardiovascular and disease-related predictors of depression in systemic lupus erythematosus. Volume 63 of Issue 4. 2011. PMID: 21452266


  147. Schmajuk G, Trivedi AN, Solomon DH, Yelin E, Trupin L, Chakravarty EF, Yazdany J. Receipt of disease-modifying antirheumatic drugs among patients with rheumatoid arthritis in Medicare managed care plans. Volume 305 of Issue 5. 2011. PMID: 21285425


  148. Katz P, Gregorich S, Yazdany J, Trupin L, Julian L, Yelin E, Criswell LA. Obesity and its measurement in a community-based sample of women with systemic lupus erythematosus. Volume 63 of Issue 2. 2011. PMID: 20824801


  149. Saag KG, Yazdany J, Alexander C, Caplan L, Coblyn J, Desai SP, Harrington T, Liu J, McNiff K, Newman E, Olson R. Defining quality of care in rheumatology: the American College of Rheumatology white paper on quality measurement. Volume 63 of Issue 1. 2011. PMID: 20945349


  150. Gillis JZ, Panopalis P, Schmajuk G, Ramsey-Goldman R, Yazdany J. Systematic review of the literature informing the systemic lupus erythematosus indicators project: reproductive health care quality indicators. Volume 63 of Issue 1. 2011. PMID: 20734353


  151. Yazdany J, Trupin L, Kaiser R, Schmajuk G, Gillis JZ, Chakravarty E, Schwarz EB. Contraceptive counseling and use among women with systemic lupus erythematosus: a gap in health care quality? Volume 63 of Issue 3. 2010. PMID: 21080446


  152. Schmajuk G, Yazdany J. Drug monitoring in systemic lupus erythematosus: a systematic review. Volume 40 of Issue 6. 2010. PMID: 21030066


  153. Hersh AO, Trupin L, Yazdany J, Panopalis P, Julian L, Katz P, Criswell LA, Yelin E. Childhood-onset disease as a predictor of mortality in an adult cohort of patients with systemic lupus erythematosus. Volume 62 of Issue 8. 2010. PMID: 20235215


  154. Schmajuk G, Yelin E, Chakravarty E, Nelson LM, Panopolis P, Yazdany J. Osteoporosis screening, prevention, and treatment in systemic lupus erythematosus: application of the systemic lupus erythematosus quality indicators. Volume 62 of Issue 7. 2010. PMID: 20589692


  155. Tonner C, Trupin L, Yazdany J, Criswell L, Katz P, Yelin E. Role of community and individual characteristics in physician visits for persons with systemic lupus erythematosus. Volume 62 of Issue 6. 2010. PMID: 20535800


  156. Yazdany J, Tonner C, Trupin L, Panopalis P, Gillis JZ, Hersh AO, Julian LJ, Katz PP, Criswell LA, Yelin EH. Provision of preventive health care in systemic lupus erythematosus: data from a large observational cohort study. Volume 12 of Issue 3. 2010. PMID: 20462444


  157. Yazdany J, Calabrese L. Preventing hepatitis B reactivation in immunosuppressed patients: is it time to revisit the guidelines? Volume 62 of Issue 5. 2010. PMID: 20191573


  158. Demas KL, Keenan BT, Solomon DH, Yazdany J, Costenbader KH. Osteoporosis and cardiovascular disease care in systemic lupus erythematosus according to new quality indicators. Volume 40 of Issue 3. 2010. PMID: 20378155


  159. Panopalis P, Gillis JZ, Yazdany J, Trupin L, Hersh A, Julian L, Criswell LA, Katz P, Yelin E. Frequent use of the emergency department among persons with systemic lupus erythematosus. Volume 62 of Issue 3. 2010. PMID: 20391487


  160. Schmajuk G, Yazdany J, Trupin L, Yelin E. Hydroxychloroquine treatment in a community-based cohort of patients with systemic lupus erythematosus. Volume 62 of Issue 3. 2010. PMID: 20391485


  161. Yazdany J, Yelin E. Health-related quality of life and employment among persons with systemic lupus erythematosus. Volume 36 of Issue 1. 2010. PMID: 20202589


  162. Panopalis P, Yazdany J. Bone health in systemic lupus erythematosus. Volume 11 of Issue 3. 2009. PMID: 19604461


  163. Yazdany J, Panopalis P, Gillis JZ, Schmajuk G, MacLean CH, Wofsy D, Yelin E. A quality indicator set for systemic lupus erythematosus. Volume 61 of Issue 3. 2009. PMID: 19248127


  164. Julian LJ, Yelin E, Yazdany J, Panopalis P, Trupin L, Criswell LA, Katz P. Depression, medication adherence, and service utilization in systemic lupus erythematosus. Volume 61 of Issue 2. 2009. PMID: 19177526


  165. Yelin E, Tonner C, Trupin L, Panopalis P, Yazdany J, Julian L, Katz P, Criswell LA. Work loss and work entry among persons with systemic lupus erythematosus: comparisons with a national matched sample. Volume 61 of Issue 2. 2009. PMID: 19177546


  166. Hersh AO, von Scheven E, Yazdany J, Panopalis P, Trupin L, Julian L, Katz P, Criswell LA, Yelin E. Differences in long-term disease activity and treatment of adult patients with childhood- and adult-onset systemic lupus erythematosus. Volume 61 of Issue 1. 2009. PMID: 19116979


  167. Panopalis P, Yazdany J, Gillis JZ, Julian L, Trupin L, Hersh AO, Criswell LA, Katz P, Yelin E. Health care costs and costs associated with changes in work productivity among persons with systemic lupus erythematosus. Volume 59 of Issue 12. 2008. PMID: 19035422


  168. Yazdany J, Maclean C. Comment on "Quality indicators for psoriatic arthritis". 2008. PMID: 19032840


  169. Katz P, Morris A, Gregorich S, Yazdany J, Eisner M, Yelin E, Blanc P. Valued life activity disability played a significant role in self-rated health among adults with chronic health conditions. Volume 62 of Issue 2. 2008. PMID: 18722089


  170. Trupin L, Tonner MC, Yazdany J, Julian LJ, Criswell LA, Katz PP, Yelin E. The role of neighborhood and individual socioeconomic status in outcomes of systemic lupus erythematosus. Volume 35 of Issue 9. 2008. PMID: 18634153


  171. Katz P, Morris A, Trupin L, Yazdany J, Yelin E. Disability in valued life activities among individuals with systemic lupus erythematosus. Volume 59 of Issue 4. 2008. PMID: 18383406


  172. Yazdany J, MacLean CH. Quality of care in the rheumatic diseases: current status and future directions. Volume 20 of Issue 2. 2008. PMID: 18349745


  173. Yazdany J, Yelin EH, Panopalis P, Trupin L, Julian L, Katz PP. Validation of the systemic lupus erythematosus activity questionnaire in a large observational cohort. Volume 59 of Issue 1. 2008. PMID: 18163398


  174. Panopalis P, Julian L, Yazdany J, Gillis JZ, Trupin L, Hersh A, Criswell LA, Katz P, Yelin E. Impact of memory impairment on employment status in persons with systemic lupus erythematosus. Volume 57 of Issue 8. 2007. PMID: 18050187


  175. Yazdany J, Gillis JZ, Trupin L, Katz P, Panopalis P, Criswell LA, Yelin E. Association of socioeconomic and demographic factors with utilization of rheumatology subspecialty care in systemic lupus erythematosus. Volume 57 of Issue 4. 2007. PMID: 17471526


  176. Gillis JZ, Yazdany J, Trupin L, Julian L, Panopalis P, Criswell LA, Katz P, Yelin E. Medicaid and access to care among persons with systemic lupus erythematosus. Volume 57 of Issue 4. 2007. PMID: 17471527


  177. Yelin E, Trupin L, Katz P, Criswell LA, Yazdany J, Gillis J, Panopalis P. Impact of health maintenance organizations and fee-for-service on health care utilization among people with systemic lupus erythematosus. Volume 57 of Issue 3. 2007. PMID: 17394180


  178. Gillis JZ, Dall'era M, Gross A, Yazdany J, Davis J. Six refractory lupus patients treated with rituximab: a case series. Volume 57 of Issue 3. 2007. PMID: 17394185


  179. Yelin E, Trupin L, Katz P, Criswell L, Yazdany J, Gillis J, Panopalis P. Work dynamics among persons with systemic lupus erythematosus. Volume 57 of Issue 1. 2007. PMID: 17266065


  180. Yazdany J, Davis J. The role of CD40 ligand in systemic lupus erythematosus. 2004. PMID: 15230296